FDA Approved: VRAYLAR — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved VRAYLAR (cariprazine) under the original application NDA204370 for the treatment of schizophrenia and manic or mixed episodes in bipolar I diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• VRAYLAR (cariprazine)

Snippet

ORIG AP for VRAYLAR (CARIPRAZINE)